Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-07-17FDA Approved: SINEMET — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Sinemet (carbidopa/levodopa) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Augmenting Effects of L-DOPS With Carbidopa and Entacapone [Phase 1, Phase 2]
This Phase 1/2 trial evaluated augmenting the norepinephrine precursor L-DOPS with carbidopa and entacapone in people with Parkinson disease…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty [Phase 2]
Phase 2 study evaluating individuals with Parkinsonian symptoms where diagnostic uncertainty exists; the study status is completed.
-
CLINICAL_TRIALS research · 2014-07-16Clinical Trial Update: Validation of DaTscan for Detection of Parkinson Disease Related Disorders
A clinical trial update reports validation efforts for DaTscan (ioflupane I-123) in detecting Parkinson disease and related movement disorde…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice
Results from a completed clinical trial assessing the safety and efficacy of pramipexole extended-release in patients with Parkinson's disea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-07-04Clinical Trial Update: Barriers to Mental Healthcare Utilization in Parkinson's Disease
A completed clinical trial conducted by Rutgers investigating barriers to utilizing mental healthcare in individuals with Parkinson's diseas…
-
CLINICAL_TRIALS research · 2014-07-01Clinical Trial Update: Role of Mesocorticolimbic Pathway in Apathy of Patients With Parkinson's Disease. - Study Using Diffusion Tensor Imaging and Fibres Tracking [NA]
This completed clinical study investigates the role of the mesocorticolimbic pathway in apathy among patients with Parkinson's disease using…
-
CLINICAL_TRIALS withdrawal · 2014-07-01Clinical Trial Update: Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating dexmedetomidine during deep brain stimulation for Parkinson's disease, essential tremor, and dystonia …
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients [Phase 3]
Phase 3 trial evaluating pramipexole in untreated and levodopa-treated Parkinson's disease patients has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China [Phase 3]
Phase 3 trial update for Rasagiline (Azilect) in levodopa-treated Parkinson's patients with motor fluctuations in China; completed with resu…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease [Phase 3]
Phase 3 trial evaluating safety and efficacy of combining pramipexole and bromocriptine with L-dopa in Parkinson disease completed.
-
CLINICAL_TRIALS research · 2014-06-23Clinical Trial Update: Efficacy of a Robotic-assisted Gait Training in Addition to a Conventional Physical Therapy in Parkinson's Disease [NA]
An update on a clinical trial evaluating whether adding robotic-assisted gait training to conventional physical therapy improves outcomes in…
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Bee Venom for the Treatment of Parkinson Disease [Phase 2]
This document provides an update on a Phase 2 clinical trial investigating bee venom as a treatment for Parkinson disease, with the study no…
-
FDA label_change · 2014-06-13FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ENTACAPONE (Sun Pharmaceutical Industries) to update labeling.
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Safety of Urate Elevation in Parkinson's Disease [Phase 2]
Phase 2 results summarize the safety findings of urate-elevating strategies in Parkinson's disease. The study is completed with results post…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a [Phase 1]
Phase 1 study evaluating the radiotracer [18F]MPPF as a brain tracer for serotonin 5-HT1A receptors, with completed status in Parkinson's di…
-
CLINICAL_TRIALS research · 2014-06-04Clinical Trial Update: Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls [Phase 1]
Phase 1 clinical trial update involving Parkinson disease, Alzheimer disease, and healthy controls; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease [Phase 3]
Phase 3b open-label trial assessing Rotigotine as an add-on to low-dose Pramipexole or Ropinirole in advanced Parkinson's disease completed,…
-
CLINICAL_TRIALS research · 2014-06-03Clinical Trial Update: Clinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's Disease [NA]
This clinical trial update describes a study of adaptive deep brain stimulation controlled by intracerebral activity in advanced Parkinson's…
-
FDA approval · 2014-06-03FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's original application for pramipexole dihydrochloride, a generic formulation indicated for trea…
-
FDA approval · 2014-05-29FDA Approved: AZILECT — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for AZILECT (rasagiline mesylate) from Teva Neuroscience, Inc.
-
CLINICAL_TRIALS research · 2014-05-29Clinical Trial Update: Mapping Functional Networks of Brain Activity (Brain Network Activation, BNA) Based on Analysis of Evoked Response Potential (ERP) Signals for Healthy Controls Evoked Response Potential (ERP) Signals for Healthy Controls and Patients With Parkinson Disease
This clinical trial update describes a study mapping functional brain networks using Brain Network Activation (BNA) derived from evoked resp…
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease [Phase 2]
Phase 2 pharmacokinetic and pharmacodynamic evaluation of the investigational drug AP09004 in patients with Parkinson's disease has complete…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa [Phase 2]
This update reports the completion of a Phase 2 trial evaluating istradefylline (KW-6002) as add-on therapy to levodopa in Parkinson's disea…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients [Phase 3]
A Phase 3 study evaluating SPM 962 in advanced Parkinson's disease, comparing against placebo and ropinirole, has completed with results pos…